Cofoe Medical Technology Co., Ltd. (Cofoe Medical) reported that on 30 October 2026 it transferred 2.07 million A shares—previously held in its repurchase account—to participants of its 2024 Stock Incentive Scheme through a non-trade transfer.
• Capital structure impact – Issued shares (excluding treasury shares) increased by 2.07 million, or 1.03%, to 203.77 million. – Treasury shares declined to 5.12 million from 7.20 million. – The company’s total share capital remains unchanged at 208.90 million shares.
• Outstanding shares awaiting cancellation Cofoe Medical still holds 2.60 million repurchased shares earmarked for cancellation. These shares were acquired in eight on-market transactions executed between 22 July and 2 September 2026 at prices ranging from RMB 48.13 to RMB 54.19 per share, representing a volume-weighted average repurchase cost of approximately RMB 51.66 per share.
The latest transfer aligns with Cofoe Medical’s equity incentive programme, reallocating previously repurchased shares to employees while modestly increasing the free-float in the market. Following the transaction, treasury stock now accounts for 2.45% of total issued shares, down from 3.45% prior to the transfer.
Comments